Leo Pharma unveils up to 250 layoffs and relocations amid CEO's revamp

Amid a transformation effort under CEO Christophe Bourdon, Danish dermatology expert Leo Pharma is embarking on another round of layoffs and relocations.

As part of the “next step” in the company’s evolving strategy, Leo is closing and relocating up to 250 roles, a company spokesperson told Fierce Pharma over email.